Christine Xu

High sustained virologic response rates in children with chronic hepatitis C receiving peginterferon alfa-2b plus ribavirin

Stefan Wirth, Carmen Ribes‐Koninckx, Maria Angeles Calzado et al. · Journal of Hepatology · 2010 · 147 citations

Pharmacy, Child Health, Infectious Diseases +14

A phase 2 randomized dose-ranging study of the JAK2-selective inhibitor fedratinib (SAR302503) in patients with myelofibrosis

Animesh Pardanani, Ayalew Tefferi, Catriona Jamieson et al. · Blood Cancer Journal · 2015 · 97 citations · Full text

Medicine, Hematology, Pharmacology +10

Applications of Quantitative Systems Pharmacology in Model‐Informed Drug Discovery: Perspective on Impact and Opportunities

Erica L. Bradshaw, Mary E. Spilker, Richard Zang et al. · CPT Pharmacometrics & Systems Pharmacology · 2019 · 87 citations · Full text

Pharmacy, Pharmacology, Drug Discovery +13

Disease–Drug Interaction of Sarilumab and Simvastatin in Patients with Rheumatoid Arthritis

Eun Bong Lee, Nikki Daskalakis, Christine Xu et al. · Clinical Pharmacokinetics · 2016 · 77 citations · Full text

Medicine, Clinical Pharmacokinetics, Pharmacology +15

IMI – Oral biopharmaceutics tools project – Evaluation of bottom-up PBPK prediction success part 2: An introduction to the simulation exercise and overview of results

Alison Margolskee, Adam S. Darwich, Xavier Pépin et al. · European Journal of Pharmaceutical Sciences · 2016 · 67 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +16